Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Maggiolini

Showing results (161-170 of 163) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 163 results.
Cell Death Discovery|September 25, 2023
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathwayFrancesca Cirillo, Marianna Talia, Maria Francesca Santolla, et al.
Cells|November 27, 2021
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer CellsVeronica Vella, Marika Giuliano, Alessandro La Ferlita, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 11, 2023
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cellsMarianna Talia, Francesca Cirillo, Asia Spinelli, et al.
Pageof 17

Showing results (161-170 of 163) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 163 results.
Cell Death Discovery|September 25, 2023
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathwayFrancesca Cirillo, Marianna Talia, Maria Francesca Santolla, et al.
Cells|November 27, 2021
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer CellsVeronica Vella, Marika Giuliano, Alessandro La Ferlita, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 11, 2023
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cellsMarianna Talia, Francesca Cirillo, Asia Spinelli, et al.
Pageof 17